GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 22 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,835 | -82.9% | 4,307 | -79.9% | 0.00% | – |
| Q4 2022 | $10,716 | +34.0% | 21,432 | -20.6% | 0.00% | – |
| Q3 2022 | $8,000 | +100.0% | 26,986 | +345.0% | 0.00% | – |
| Q2 2022 | $4,000 | -66.7% | 6,064 | -4.6% | 0.00% | – |
| Q4 2021 | $12,000 | – | 6,356 | +3872.5% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 160 | -95.3% | 0.00% | – |
| Q1 2021 | $12,000 | -62.5% | 3,418 | -66.8% | 0.00% | – |
| Q4 2020 | $32,000 | +966.7% | 10,309 | +1528.6% | 0.00% | – |
| Q2 2020 | $3,000 | -75.0% | 633 | -81.9% | 0.00% | – |
| Q1 2020 | $12,000 | +200.0% | 3,500 | +382.1% | 0.00% | – |
| Q4 2019 | $4,000 | -55.6% | 726 | -38.8% | 0.00% | – |
| Q2 2019 | $9,000 | +125.0% | 1,186 | +107.0% | 0.00% | – |
| Q4 2018 | $4,000 | -99.2% | 573 | -98.4% | 0.00% | – |
| Q3 2018 | $488,000 | +14.6% | 35,919 | +0.4% | 0.00% | – |
| Q2 2018 | $426,000 | +91.0% | 35,778 | -10.6% | 0.00% | – |
| Q1 2018 | $223,000 | +3085.7% | 40,000 | +5334.8% | 0.00% | – |
| Q4 2017 | $7,000 | -85.4% | 736 | -90.5% | 0.00% | – |
| Q2 2017 | $48,000 | – | 7,711 | +256933.3% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 3 | -99.9% | 0.00% | – |
| Q3 2016 | $17,000 | +466.7% | 3,787 | +529.1% | 0.00% | – |
| Q1 2016 | $3,000 | -91.4% | 602 | -87.0% | 0.00% | – |
| Q4 2015 | $35,000 | +191.7% | 4,619 | +179.1% | 0.00% | – |
| Q3 2015 | $12,000 | +300.0% | 1,655 | +410.8% | 0.00% | – |
| Q2 2015 | $3,000 | -91.9% | 324 | -91.7% | 0.00% | – |
| Q1 2015 | $37,000 | +311.1% | 3,902 | +143.0% | 0.00% | – |
| Q4 2014 | $9,000 | – | 1,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|